The Caixin Must-Read newsletter brings you the best of our coverage over the past week, handpicked by our editors.
In Depth: Why China’s Exports Are in the Doldrums
Demand has fallen off in recent months in the country’s three biggest markets, though the reasons vary by region
In Depth: What’s in Store for China GDP, Fiscal Policy in 2023
As policymakers prioritize economic recovery, analysts expect more fiscal support through a higher budget deficit and a bigger special bond quota for local governments
China’s Drive to Kick the Foreign IT Habit
Government presses state-owned enterprises to buy domestic tech products as U.S. sanctions bite, spurring a surge in homegrown application innovations
China Real Estate’s Nagging Woes Are ‘Top Priority,’ State Economist Says
Han Wenxiu, deputy chief of a leading economic body’s general office, advocates ending a years-long pattern of high debt, high leverage and quick turnover
In Depth: How China Helped Build Indonesia’s High-Speed Rail
The Jakarta-Bandung link, a $7.36 billion Belt and Road project, overcame property disputes, construction hurdles, cost overruns and the pandemic
China’s State Drugmakers Scramble to Stock Pharmacy Shelves Amid Run on Covid Medicines
Sinopharm and China General Technology boost production, with deliveries running around the clock after the sudden reversal of ‘zero-Covid’
In Depth: Strict Rules at Home Push Chinese Metaverse Entrepreneurs, Investors Overseas
The scramble to monetize the metaverse and web3 is in full swing, as a new phase of the internet based on cryptocurrency and blockchain technology takes shape
Analysis: How China Counts — and Doesn't Count — Covid Deaths
The classification offers clues as to why the cases of a 74-year-old man and a university student, both of whom caught the virus and died last week, were considered non-Covid deaths
Hong Kong Approval Expands Mainlanders’ Access to mRNA Covid Shots
BioNTech vaccine marketed by Fosun Pharma wins official registration, elevating authorization from emergency use
China’s Demand for Pfizer’s Paxlovid Skyrockets, but Supplies Are Limited
As Covid cases climb, the State Council has allowed medical institutions to do online prescribing of drugs used to treat Covid-related symptoms
Related
China to Boost Supply of Pfizer’s Covid Pill as Demand Soars, Expert Says
Wang Tao: Key Takeaways From China’s Central Economic Work Conference
Stabilizing growth is the top priority, with measures to boost the real estate sector and a supportive tone for non-SOEs, foreign investors and online platforms
There Is More to China’s Drop in Consumer Spending Than Covid-19
Consumption won’t rebound just because Covid policies have been relaxed. Multiple factors have upended household balance sheets, leaving them with reduced income and uncertain futures
Gallery: Vegetable Growers in a Pickle
China Green Finance with a Cup of Tea Episode 3: China's Green Credit Market
Caixin Global invited Dr. GUO Peiyuan, Chairman of SynTao Green Finance, to share his insights on what international investors should know about China's green credit market.
Caixin Global’s Top Stories of the Month newsletter brings you the most popular news coverage over the past month. You may opt in now and get handpicked news coverage delivered to your inbox each month for free.
